“ Therapeutic Monoclonal Antibodies: ScFv Patents As a Marker of a New Class of Potential Biopharmaceuticals ”. Brazilian Journal of Pharmaceutical Sciences, vol. 47, no. 1, Mar. 2011, pp. 31-38, https://doi.org/10.1590/S1984-82502011000100005.